Form 8-K - Current report:
SEC Accession No. 0000950170-25-090522
Filing Date
2025-06-27
Accepted
2025-06-26 18:00:29
Documents
13
Period of Report
2025-06-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20250623.htm   iXBRL 8-K 51151
2 EX-3.1 hura-ex3_1.htm EX-3.1 2794
3 GRAPHIC img200812020_0.jpg GRAPHIC 673262
4 GRAPHIC img200812020_1.jpg GRAPHIC 549670
  Complete submission text file 0000950170-25-090522.txt   1855601

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250623.xsd EX-101.SCH 31885
16 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250623_htm.xml XML 4899
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 251081609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)